Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou Jinyuan Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of chemical drug substances and finished dosage forms. The company's product portfolio primarily covers therapeutic areas such as cardiovascular health, respiratory diseases, and anti-infectives. Key products include generic versions of widely used medications like amlodipine besylate for hypertension and various macrolide antibiotics. Changzhou Jinyuan operates GMP-certified manufacturing facilities to supply both domestic and international markets. The company focuses on providing high-quality, affordable generic medicines through integrated production capabilities. It is recognized as a high-tech enterprise within the Jiangsu province pharmaceutical cluster.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 常州金远药业.